Questions Over Avandia Disclosures Prompt FDA Probe

Questions Over Avandia Disclosures Prompt FDA Probe
Avandia may be about to cause more trouble for GlaxoSmithKline. According to a report in TIME Magazine, the US Food & Drug Administration (FDA) is trying to determine if Glaxo broke the law when it didn’t disclose data on the controversial diabetes drug’s heart risks. Since November 2007, Avandia’s label has included a black box [...]

Read more on NewsInferno